SARS-COV-2 Infections Post Vaccination | Public Health and CDC/FDA Updates | May 17, 2021
Date of Presentation: May 17, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #breakthrough infections #covid resource drop #public health updates
In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, reviews the latest articles on SARS-COV-2 infections following COVID-19 vaccination. Then, Dr. Eileen M. Dunne, PhD, ECHO faculty member and Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention at the Idaho Division of Public Health, provides a public health practice update and a number of valuable COVID-19 related resources produced by HHS, CDC and FDA.
Recording:
Presented by:
Dr. Tom Becker, Dr. Eileen M. Dunne
Thomas Becker, MD, PhD, is a medical epidemiologist, and trained in internal medicine, anthropology, and public health; he began his career at the University of New Mexico before moving to the Northwest about 20 years ago. Since his arrival in Portland, Becker has worked with the Northwest Portland Area Indian Health Board and Oregon Health & Science University. He has published on a diverse range of American Indian health issues, including both infectious and chronic diseases. And with the Indian Health Board, he has been involved in etiologic studies, community prevention programs and education programs to improve career opportunities for people in tribes nationwide.
Eileen M. Dunne, PhD, is an Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention assigned to the Idaho Department of Health & Welfare. Eileen has a Ph.D. in microbiology from Boston University and spent nine years at the Murdoch Children’s Research Institute in Melbourne, Australia conducting clinical research on pediatric infections and pneumococcal vaccines. Her primary interests include infectious diseases, immunization, and public health.
Resources Provided:
- SARS-COV-2 Infections following COVID-19 Vaccination (Presentation Slides)
- Public Health and Practice Updates (Presentation Slides)
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants (NEJM)
- What Should Define a SARS-CoV-2 "Breakthrough" Infection (pre-print)
- Postvaccination SARS-CoV-2 Infections Among Skilled Nursing Facility Residents and Staff Members — Chicago, Illinois, December 2020–March 2021 (MMWR)
- Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers (JAMA)
- Vaccine Effectiveness against Variants in Qatar (Lancet)
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12-15 Years (MMWR)
- Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios (MMWR)
- Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429 (MMWR)
- Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant (MMWR)
- Demographic and Social Factors Associated with COVID-19 Vaccination Initiation Among Adults Aged ?65 Years (MMWR)
- What Really Happened With that Weird Yankees COVID Outbreak (NYmag)
- BinaxNOW™ COVID-19 Ag Card Product Expiry Update
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic (FDA)
- Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization
- Pfizer-BioNTech COVID-19 Vaccine fact sheet for providers
- ACIP evidence for Pfizer COVID-19 vaccine recommendations
- Interim Public Health Recommendations for Fully Vaccinated People (CDC)
- COVID-19 Data Tracker (CDC)
- COVID-19 Vaccine Breakthrough Cases (CDC)
Date added: May 17, 2021